Sailors Arrive Safely in Delaware; Generous Donors Contribute Over $31,000 to Pancreatic Cancer Research and Treatment
QuestaWeb, Inc. proudly announces that key milestones have been achieved in its effort to bring attention to finding a cure for pancreatic cancer and advancing current treatment techniques. The fundraiser, launched on May 6, 2015, combined an epic sailing adventure undertaken by QuestaWeb CEO Leon Turetsky and a digital fundraising campaign led by QuestaWeb COO Felix Pekar. Turetsky and two fellow sailors arrived in Delaware City, Delaware on June 21, almost two weeks ahead of the projected arrival date for the Greece-to-America voyage. The digital effort, which employed the City of Hope ourHope platform, email and popular social media sites, surpassed the initial $25,000 goal due to the exceptional generosity of donors. QuestaWeb is humbled by the outpouring of support and extends a sincere thank you to the many generous friends and family members who made a donation and lent their support to the effort. All of the funds raised go directly to City of Hope
QuestaWeb’s fundraiser page explains the motivation behind the effort:
Two years ago, QuestaWeb COO Felix Pekar and his wife received the devastating diagnosis that she had pancreatic cancer. Alexandra, a vibrant woman in the prime of her life, underwent surgery and extensive radiation and chemotherapy treatments. Thankfully, she is in remission today, but ever aware that there is no cure for this deadly disease.
Page visitors received daily updates on Turetsky’s progress and could track the amount of funds raised against the goal. QuestaWeb also employed Facebook, LinkedIn, Twitter and YouTube to share updates, photos and videos.
Leon Turetsky, QuestaWeb CEO, said, “On behalf of the entire QuestaWeb family, thank you to everyone who supported our effort with their prayers, good wishes and financial contributions. This accomplishment would not have been possible without you. We also thank the Stephenson Family whose generous match program through the City of Hope helped us reach our goal.”
Contributions to the QuestaWeb fundraiser are being accepted through July 31, 2015. Please visit QuestaWeb Sails for Pancreatic Cancer Cure and make a donation today.
About City of Hope
City of Hope is an independent research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope also is a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope’s main hospital is located in Duarte, California, with community clinics in southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics.
QuestaWeb is a premier provider of integrated, web-based global trade management software solutions. The firm’s business model unifies import, export, logistics, compliance and financial processes including U.S. Customs clearance, landed costs, Harmonized Tariff Schedule classifications, export licensing, denied party screening, quota management, product catalog, tracking, event management and international document repository. The centralized global database maintains up-to-date compliance content and supports multiple languages, currencies and time zones. QuestaWeb was one of the first companies certified by U.S. Customs for ABI electronic connectivity initiatives and the first ACE-certified vendor. The company’s flagship product, TradeMasterQW Global Trade Management System, proactively manages export and import processes for importers, exporters, brokers and forwarders. It accelerates the flow of goods across the global supply chain, reduces inventory and operational costs and ensures compliance with ever-changing cross-border regulations. To learn more about QuestaWeb, please visit www.questaweb.com or call 908-233-2300.